derinet® Switzerland
Product names from:
VontobelSVSP
Back

Express VONCERT on AbbVie Inc, Bristol-Myers Squibb, Fresenius & KGaA, Gilead Sciences (Quanto CHF)

  • Valor 46468769
  • ISIN CH0464687695
  • Symbol
sustainable
Bid (indicative)%
Ask (indicative)%
CurrencyCHF
Price on
  • Quanto
  • Barrier observation at the end
  • Autocallable
  • sustainable
AbbVie IncUSD 
Bristol-Myers Squibb Co.USD 
Fresenius SE & Co. KGaAEUR 
Gilead Sciences Inc.USD 
Please note that this is an indication.

Documents

Life cycle
Initial fixing11/03/2019
Payment date18/03/2019
Last trading day11/09/2020
Final fixing11/09/2020
Redemption18/09/2020

Current price information

Intraday1 week1 monthSince emission
until
I18N_ProductUnderlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
USD 71.67USD 62.28USD 50.60
USD 50.07USD 40.81USD 33.16
EUR 45.315EUR 38.40EUR 31.20
USD 65.96USD 51.23USD 41.63

No chart available

Life cycle
Initial fixing11/03/2019
Payment date18/03/2019
Last trading day11/09/2020
Final fixing11/09/2020
Redemption18/09/2020
Figures
Product typeExpress VONCERT
SSPA categorisationExpress Certificate
Issue price100.00%
Reference currencyCHF
QuantoYes
BarrierUSD 50.60
Barrier observationat the end
Underlying/
ISIN of underlying
AbbVie Inc
US00287Y1091
Spot reference priceUSD 77.85
COSINo
ListingNone
Additional conditions
IssuerVontobel Financial Products Ltd., DIFC Dubai
GuarantorVontobel Holding AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliveryphysical delivery
Issuance ProgrammeLink to the Issuance Program